This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The Moderna trial was randomized and ...
ISSAQUAH, WA / ACCESSWIRE / November 14, 2024 / CaaMTech, Inc. is pleased to announce positive feedback from United States federal government regulators for its CT-4201 psilocin prodrug program.
<p><i><strong>CaaMTech’s New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine Developers</strong></i></p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results